Developer docs
API playgroundTry for free, no card

Search company profiles

Alcimed

Full company profile

uuid0009me7

Namestring
Alcimed
Legal namestring
Alcimed SAS
Websiteurl
alcimed.com
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Alcimed is an innovation and new business consulting firm headquartered in Paris, founded in 1993. The firm employs approximately 220 highly-qualified consultants ('explorers') with blended science/technology and business backgrounds, distributed across eight offices in France, Europe (including Germany via subsidiary Alcimed GmbH in Cologne), the United States, and Singapore. It serves private and public decision-makers — large industrial leaders, SMEs, innovative startups, and government institutions — across ten verticals: Healthcare, Biotech, Aeronautics Space Defense, Energy & Environment, Agrifood, Chemicals & Materials, Cosmetics & Luxury, Public Policy, Mobility, and Private Equity. Named clients include Sanofi, Roche, Bayer, Johnson & Johnson, Moderna, Boehringer Ingelheim, Airbus, Thales, TotalEnergies, L'Oréal, Nestlé, Mars, Michelin, Saint-Gobain, Solvay, and Suez, alongside French government bodies including APHP and the Ministère de la Santé.

Alcimed's service catalog spans seven mission types — strategic marketing, clients & patients, R&D, commercial strategy, innovation, new partners, and strategy — delivered through a mix of secondary research (literature review, internal/external data lake analysis using data science) and primary stakeholder interviews. Deliverables extend beyond traditional consulting decks to include videos, data visualization tools, collaborative platforms, and interactive animations (escape games, quizzes, board games). The firm also operates sub-brands Nautilus.ai (an AI-in-healthcare initiative), the Oncology Exploration Center, and an interactive AI-in-Healthcare map.

Revenue is generated through project-based and multi-year retainer professional services engagements, priced custom per scope. The firm is privately held as an SAS under French law with EUR 500,000 share capital and no disclosed external investment or parent company. Valérie Kniazeff serves as Présidente. In December 2023, Alcimed launched the Fondazione Alcimed per le Malattie Rare, a corporate foundation offering pro bono consulting to patients and patient associations affected by rare diseases.

Short descriptiontext

Alcimed is a Paris-based innovation and new business consulting firm, founded in 1993, with ~220 consultants across 8 global offices serving enterprise, SME, startup, and government clients in 10 innovation-driven sectors including healthcare, biotech, energy, mobility, and aerospace.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
innovation consulting services, strategy consulting, market entry advisory, R&D strategy consulting, business development consulting
Industry3 codes
PRIMARYBPAHAEAL
Emerging Tech (IoT, Blockchain, AR/VR, Edge) Consulting
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYBPAHAJAF
EHS Management Systems & ISO Consulting (ISO 14001/45001)
NAICS code3 codes
  • Marketing Consulting Services541613
  • Other Scientific and Technical Consulting Services54169
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Innovation Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Innovation and New Business Consulting Services
TypeProfessional Services
Description

Alcimed generates revenue by providing consulting services to private and public decision-makers. Projects cover strategic marketing, R&D strategy, commercial strategy, innovation strategy, new partner identification, market studies, go-to-market strategy, business development, regulatory analysis, and technology scouting. Revenue is derived from professional services engagements, typically billed on a project or retainer basis.

alcimed.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Custom consulting engagement
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is determined on a per-project basis. No public pricing is available. Initial consultations are offered for free. Alcimed works with large industrial leaders, SMEs, startups, and institutions across multiple sectors.

alcimed.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Nautilus.ai
Description

An AI-powered tool developed by Alcimed for exploring AI applications in healthcare.

alcimed.com
Core offering1 text field

Alcimed is an innovation and new business consulting firm that helps private and public decision-makers explore and develop uncharted territories. Their services span strategic marketing, R&D strategy, commercial strategy, innovation strategy, new partner identification, market studies, go-to-market strategy, business development, regulatory analysis, and technology scouting across 10 sectors including Healthcare, Biotech, Aeronautics Space Defense, Energy & Environment, Agrifood, Chemicals & Materials, Cosmetics & Luxury, Public Policy, Mobility, and Private Equity.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 120+ oncology projects completed in the last 5 years
+2 more records
Product overview1 text field

Alcimed is an innovation and new business consulting firm (not a software product company). It provides consulting services across multiple sectors including Healthcare, Biotech, Aeronautics Space Defense, Energy & Environment, Agrifood, Chemicals & Materials, Cosmetics & Luxury, Public policy, Mobility, and Private Equity. The firm's service offerings include strategic marketing, clients & patients engagement, R&D, commercial strategy, innovation, new partners development, and strategy consulting. Specific service offerings include competitive analysis, market analysis, proof of concept, and various specialized consulting missions. Alcimed does not offer software products, platforms, or SaaS solutions.

Product and service7 records
1Strategic Marketing Consulting
CategoryStrategy Consulting
Description

Consulting missions covering new offer development, competitive analysis, new services development, brand planning, product launch support, and opportunity evaluation for enterprise clients.

2Clients & Patients Engagement Consulting
CategoryCustomer Engagement Consulting
Description

Engagement-focused consulting covering marketing activation, customer engagement, customer journey mapping, patient pathway analysis, benchmarking, market analysis, customer experience, and voice of customer research.

3R&D Strategy Consulting
CategoryR&D Advisory
Description

R&D-focused consulting covering funding opportunity searches, regulatory framework analysis, in- and out-licensing, funding application dossiers, R&D strategy, and state-of-the-art reviews for life sciences and industrial clients.

4Commercial Strategy Consulting
CategoryCommercial Consulting
Description

Commercial strategy engagements covering market access, go-to-market planning, commercial strategy design, and business development support for clients entering or expanding in markets.

5Innovation Consulting
CategoryInnovation Consulting
Description

Innovation-focused consulting covering open innovation, workshops, learning expeditions, innovation strategy, test and learn programs, product innovation, funding applications, and proof of concept development.

6New Partners Consulting
CategoryPartnership Consulting
Description

Partner identification and development consulting covering technology scouting, partner searches, public-private partnerships, and collaborative project support for clients seeking R&D and commercial partners.

7Strategy Consulting
CategoryStrategy Consulting
Description

Corporate and business strategy consulting covering strategic positioning, value proposition design, business case development, business planning, project roadmaps, business model innovation, strategic due diligence, and strategic audits.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global top-tier management consulting firm with deep practices in healthcare, consumer goods, and industrials. Frequently competes with Alcimed for blue-chip French and European strategy mandates.

TypeDirect peer
Description

Global management and strategy consulting firm combining technology, innovation, and sector expertise. Closely aligned to Alcimed's mix of strategy, R&D, and innovation consulting across healthcare, energy, and mobility.

TypeBroad incumbent
Description

Global management consulting leader with deep innovation and healthcare practices (e.g., BCG X). Largest category competitor for European enterprise innovation consulting work.

TypeDirect peer
Description

European-origin strategy and management consulting firm of broadly comparable size and cross-sector coverage including industrials, healthcare, and energy. Comparable mid-tier alternative to large MBAs with similar vertical specialization approach.

TypeDirect peer
Description

European strategy boutique focused on growth, innovation, and new business development for industrial and consumer clients. Closely comparable offering to Alcimed's strategic marketing and new offers missions.

TypeBroad incumbent
Description

Global management consulting firm serving industrial and consumer clients with strategy, operations, and procurement work. Overlaps with Alcimed's innovation and commercial strategy missions in aeronautics, chemicals, and consumer goods.

TypeBroad incumbent
Description

Global management consulting firm with strong industrials, energy, and healthcare practices that often run alongside strategic marketing and innovation engagements. Comparable client roster in large European corporates.

TypeRegional player
Description

European-origin consulting firm focused on operational and strategic transformation across sectors. Comparable in size and geographic footprint to Alcimed, with overlapping client base among industrial and public-sector buyers.

TypeDirect peer
Description

Paris-headquartered management and technology consulting firm with comparable European reach and sector breadth. Competes head-to-head for French enterprise and public-sector innovation mandates.

10Kea & Partners
TypeDirect peer
Description

French innovation, transformation, and strategy consulting firm with similar DNA in blending business and tech. Most direct European boutique peer for innovation, new offers, and transformation work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers21 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment12 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alcimed

Innovation Consultingalcimed.com

Alcimed is a Paris-based innovation and new business consulting firm, founded in 1993, with ~220 consultants across 8 global offices serving enterprise, SME, startup, and government clients in 10 innovation-driven sectors including healthcare, biotech, energy, mobility, and aerospace.

What Alcimed does

Alcimed is an innovation and new business consulting firm headquartered in Paris, founded in 1993. The firm employs approximately 220 highly-qualified consultants ('explorers') with blended science/technology and business backgrounds, distributed across eight offices in France, Europe (including Germany via subsidiary Alcimed GmbH in Cologne), the United States, and Singapore. It serves private and public decision-makers — large industrial leaders, SMEs, innovative startups, and government institutions — across ten verticals: Healthcare, Biotech, Aeronautics Space Defense, Energy & Environment, Agrifood, Chemicals & Materials, Cosmetics & Luxury, Public Policy, Mobility, and Private Equity. Named clients include Sanofi, Roche, Bayer, Johnson & Johnson, Moderna, Boehringer Ingelheim, Airbus, Thales, TotalEnergies, L'Oréal, Nestlé, Mars, Michelin, Saint-Gobain, Solvay, and Suez, alongside French government bodies including APHP and the Ministère de la Santé.

Alcimed's service catalog spans seven mission types — strategic marketing, clients & patients, R&D, commercial strategy, innovation, new partners, and strategy — delivered through a mix of secondary research (literature review, internal/external data lake analysis using data science) and primary stakeholder interviews. Deliverables extend beyond traditional consulting decks to include videos, data visualization tools, collaborative platforms, and interactive animations (escape games, quizzes, board games). The firm also operates sub-brands Nautilus.ai (an AI-in-healthcare initiative), the Oncology Exploration Center, and an interactive AI-in-Healthcare map.

Revenue is generated through project-based and multi-year retainer professional services engagements, priced custom per scope. The firm is privately held as an SAS under French law with EUR 500,000 share capital and no disclosed external investment or parent company. Valérie Kniazeff serves as Présidente. In December 2023, Alcimed launched the Fondazione Alcimed per le Malattie Rare, a corporate foundation offering pro bono consulting to patients and patient associations affected by rare diseases.

Alcimed firmographics

Firmographics
Name
Alcimed
Legal name
Alcimed SAS
Website
https://alcimed.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
101–250 employees
Short description
Alcimed is a Paris-based innovation and new business consulting firm, founded in 1993, with ~220 consultants across 8 global offices serving enterprise, SME, startup, and government clients in 10 innovation-driven sectors including healthcare, biotech, energy, mobility, and aerospace.
Ownership category
akta.pro rank

Alcimed industry classification

Industry
Product category
Innovation Consulting
NAICS
Marketing Consulting Services (541613), Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAHAEAL
Emerging Tech (IoT, Blockchain, AR/VR, Edge) Consulting
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYBPAHAJAF
EHS Management Systems & ISO Consulting (ISO 14001/45001)

Keywords

  • Innovation consulting services
  • Strategy consulting
  • Market entry advisory
  • R&D strategy consulting
  • Business development consulting

Where Alcimed is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices5 records

Markets served

Alcimed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Innovation and New Business Consulting Services: Alcimed generates revenue by providing consulting services to private and public decision-makers. Projects cover strategic marketing, R&D strategy, commercial strategy, innovation strategy, new partner identification, market studies, go-to-market strategy, business development, regulatory analysis, and technology scouting. Revenue is derived from professional services engagements, typically billed on a project or retainer basis.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom consulting engagement

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Alcimed product offering

Product offering

Core offering

Alcimed is an innovation and new business consulting firm that helps private and public decision-makers explore and develop uncharted territories. Their services span strategic marketing, R&D strategy, commercial strategy, innovation strategy, new partner identification, market studies, go-to-market strategy, business development, regulatory analysis, and technology scouting across 10 sectors including Healthcare, Biotech, Aeronautics Space Defense, Energy & Environment, Agrifood, Chemicals & Materials, Cosmetics & Luxury, Public Policy, Mobility, and Private Equity.

Product overview

Alcimed is an innovation and new business consulting firm (not a software product company). It provides consulting services across multiple sectors including Healthcare, Biotech, Aeronautics Space Defense, Energy & Environment, Agrifood, Chemicals & Materials, Cosmetics & Luxury, Public policy, Mobility, and Private Equity. The firm's service offerings include strategic marketing, clients & patients engagement, R&D, commercial strategy, innovation, new partners development, and strategy consulting. Specific service offerings include competitive analysis, market analysis, proof of concept, and various specialized consulting missions. Alcimed does not offer software products, platforms, or SaaS solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • Nautilus.ai: An AI-powered tool developed by Alcimed for exploring AI applications in healthcare.

Products and services

  • Strategic Marketing Consulting Consulting missions covering new offer development, competitive analysis, new services development, brand planning, product launch support, and opportunity evaluation for enterprise clients.
  • Clients & Patients Engagement Consulting Engagement-focused consulting covering marketing activation, customer engagement, customer journey mapping, patient pathway analysis, benchmarking, market analysis, customer experience, and voice of customer research.
  • R&D Strategy Consulting R&D-focused consulting covering funding opportunity searches, regulatory framework analysis, in- and out-licensing, funding application dossiers, R&D strategy, and state-of-the-art reviews for life sciences and industrial clients.
  • Commercial Strategy Consulting Commercial strategy engagements covering market access, go-to-market planning, commercial strategy design, and business development support for clients entering or expanding in markets.
  • Innovation Consulting Innovation-focused consulting covering open innovation, workshops, learning expeditions, innovation strategy, test and learn programs, product innovation, funding applications, and proof of concept development.
  • New Partners Consulting Partner identification and development consulting covering technology scouting, partner searches, public-private partnerships, and collaborative project support for clients seeking R&D and commercial partners.
  • Strategy Consulting Corporate and business strategy consulting covering strategic positioning, value proposition design, business case development, business planning, project roadmaps, business model innovation, strategic due diligence, and strategic audits.

Quantifiable outcome

  • 120+ oncology projects completed in the last 5 years
  • +2 more outcomes

Companies that use Alcimed

Customer profile

Named customers21 records

Segments12 records

Ideal customer profiles4 records

Alcimed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Alcimed partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Alcimed competitors and assessment

Company assessment

Broad incumbents

  • Bain & Company: Global top-tier management consulting firm with deep practices in healthcare, consumer goods, and industrials. Frequently competes with Alcimed for blue-chip French and European strategy mandates.
  • Boston Consulting Group (BCG): Global management consulting leader with deep innovation and healthcare practices (e.g., BCG X). Largest category competitor for European enterprise innovation consulting work.
  • Kearney: Global management consulting firm serving industrial and consumer clients with strategy, operations, and procurement work. Overlaps with Alcimed's innovation and commercial strategy missions in aeronautics, chemicals, and consumer goods.
  • Oliver Wyman: Global management consulting firm with strong industrials, energy, and healthcare practices that often run alongside strategic marketing and innovation engagements. Comparable client roster in large European corporates.

Direct peers

  • Arthur D. Little: Global management and strategy consulting firm combining technology, innovation, and sector expertise. Closely aligned to Alcimed's mix of strategy, R&D, and innovation consulting across healthcare, energy, and mobility.
  • Roland Berger: European-origin strategy and management consulting firm of broadly comparable size and cross-sector coverage including industrials, healthcare, and energy. Comparable mid-tier alternative to large MBAs with similar vertical specialization approach.
  • CBX (formerly Cube64): European strategy boutique focused on growth, innovation, and new business development for industrial and consumer clients. Closely comparable offering to Alcimed's strategic marketing and new offers missions.
  • Sia Partners: Paris-headquartered management and technology consulting firm with comparable European reach and sector breadth. Competes head-to-head for French enterprise and public-sector innovation mandates.
  • Kea & Partners: French innovation, transformation, and strategy consulting firm with similar DNA in blending business and tech. Most direct European boutique peer for innovation, new offers, and transformation work.

Regional players

  • Eurogroup Consulting: European-origin consulting firm focused on operational and strategic transformation across sectors. Comparable in size and geographic footprint to Alcimed, with overlapping client base among industrial and public-sector buyers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Alcimed social profiles

Digital presence

Alcimed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alcimed leadership team

Management profile

Number of profiles

Profiles2 records

Alcimed subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Alcimed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alcimed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alcimed

What does Alcimed do?

Alcimed is an innovation and new business consulting firm that helps private and public decision-makers explore and develop uncharted territories. Their services span strategic marketing, R&D strategy, commercial strategy, innovation strategy, new partner identification, market studies, go-to-market strategy, business development, regulatory analysis, and technology scouting across 10 sectors including Healthcare, Biotech, Aeronautics Space Defense, Energy & Environment, Agrifood, Chemicals & Materials, Cosmetics & Luxury, Public Policy, Mobility, and Private Equity.

Is Alcimed a public or private company?

Alcimed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Alcimed founded?

Alcimed was founded in 1993. It employs 101 to 250 people.

Where is Alcimed based?

Alcimed is headquartered in Paris, France, in the Europe region.

How does Alcimed make money?

One revenue line is on record: innovation and New Business Consulting Services.

Who are Alcimed's main competitors?

Broad incumbents on record are Bain & Company, Boston Consulting Group (BCG), Kearney and Oliver Wyman. Direct peers are Arthur D. Little, Roland Berger, CBX (formerly Cube64), Sia Partners and Kea & Partners. Eurogroup Consulting is listed as a regional player.

Does Alcimed have an API?

No public API is recorded for Alcimed.

What industry is Alcimed in?

Alcimed's product category is Innovation Consulting. Its primary akta.pro industry code is BPAHAEAL, Emerging Tech (IoT, Blockchain, AR/VR, Edge) Consulting, with a secondary code of HLAIALAH, Regulatory Strategy & IND/NDA/BLA Submissions Support. Its NAICS code is 541613 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AlcimedGo-to-market in the Pharma IndustryThe article outlines the go-to-market strategies provided by Alcimed to clients in the pharmaceutical industry, including support for market access and commercial planning. It highlights the firm's specialization in life sciences innovation and its global operational presence across France, Europe, Singapore, and the USA.AlcimedInnovation ConsultingAlcimed, a consulting firm specialized in innovation and new market development, provides services to industrial leaders, SMEs, start-ups, and institutional investors. The company operates through 8 offices globally with a team of 220 consultants supporting various strategic and operational innovation projects.AlcimedBiomimicry: Find inspiration for innovationAlcimed offers specialized consulting services to help companies integrate biomimicry into their R&D processes for innovation in sectors like materials, energy, and chemistry. The article outlines key challenges in the field, such as establishing multidisciplinary study groups and identifying new biological inspirations beyond current limited species.Alcimed3 innovative greenhouses to address climate change challenges and ensure crop productionAlcimed presents three innovative greenhouse technologies designed to mitigate climate change impacts on agriculture: seawater desalination systems, transparent infrared solar panels, and AI-driven autonomous farming. These solutions aim to address water scarcity, reduce energy reliance, and improve crop yields through precision resource management despite current technical or regulatory hurdles. The report highlights the potential of these methods to enhance food security while noting challenges such as efficiency limits and policy conflicts.Alcimed5 mental health technologies with the potential to greatly improve care and efficacy of current therapiesAlcimed identifies five emerging mental health technologies—digital therapeutics, non-invasive brain stimulation, brain implants, transcranial magnetic stimulation, and virtual reality therapy—as potential solutions to improve care efficacy and reduce reliance on drug-based treatments. The article highlights specific developments such as the FDA approval of EndeavorRx for ADHD and Breakthrough Device designation for OxfordVR's schizophrenia treatment, noting that clinical trials are actively validating these approaches.THISDAYLIVEAlcimed, the consulting Firm for Innovation Enthusiasts – THISDAYLIVEAlcimed, an innovation consulting firm founded in the 1990s, guides companies in healthcare, biotechnology, energy, and digital transformation. It operates in France, Germany, Switzerland, Italy, the US, and Asia, and emphasizes strategic partnerships and sustainable innovation.Alcimed5 challenges to ensure wind energy development through the energy transitionAn Alcimed consultant outlines five obstacles to wind energy development: supply chain disruptions from the pandemic and the Ukraine war, industrial policies such as the US Inflation Reduction Act and Europe's 40% European manufacturing target, tripling of steel, copper and aluminum prices, a shortage of maintenance technicians, and turbine reliability issues. The piece notes 2022 wind investment reached a record $185 billion, up 20%.